By
MikeH on
January 21, 2013
A fellow person with diabetes from Germany has braved the open ocean and sailed around the world despite his living with type 1 diabetes.
But when it comes to getting his D-devices to talk to each other and share data, adventure sailor Bastian Hauck feels it’s like sailing against the wind into rocky waters.
“I have four devices, three cables, and one app… that’s the problem we face today,” the 34-year old type 1 said.…
Read more »
High on the wish list for PWDs is cheaper insulin. Costing over $100 a bottle (without insurance), this life-saving liquid can drain your bank account faster than your blood sugar goes up after a bowl of cereal. With so many over-the-counter and prescription drugs going generic and finally saving patients hundreds of dollars, naturally we’re wondering, “When on earth are we gonna get generic insulin?”
Sadly, probably not anytime soon.
Bio-What?
In fact, there really…
Read more »
As patients, we all know that millions (billions?) of dollars get thrown around in the Pharma and healthcare industries that may not ever touch us directly. Are all those dollars spent on marketing and research really providing the value they propose? Two related posts/discussions by industry insiders caught my eye lately:
The Downside (and Upside) of Drug Ads
In this piece from the Wall St. Journal Health Blog, Novartis CEO Dan Vasella admits that…
Read more »
In our emerging world of web-based health offerings and Net-informed patients, it looks like the name-game is still heating up. Recently I sounded off about whether we should be referred to now as patients or consumers, and don’t forget the term “ePatients” — along with eHeath Consumers, Cybercitizens, etc., etc.
Now Manhattan Research, a highly respected pharmaceutical and healthcare market research firm, has invented a new buzz-term for consumers who use the Internet to research…
Read more »
